Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the UBS Global Healthcare Conference in New York, NY on Tuesday, May 20, 2014 at 1:30 p.m. Eastern Time. Chris Garabedian, president and chief executive officer, will be the presenter.
Help employers find you! Check out all the jobs and post your resume.
